Activation of human complement system in paracoccidioidomycosis

REFERENCES

• Almedia F.O. Estudos comparativos do granuloma coccidioidico nos Estados Unidos e no Brasil — novo genero para o parasita brasileiro. Anais da Faculdade de Medicina e Universidade de São Paulo 1930; 5: 125–141
   Google Scholar
• Arango M., Oropeza F., Anderson O., Contreras C., Bianco N., Yarzabal L. Circulating immune complexes and in vitro cell reactivity in paracoccidioidomycosis. Mycopathologia 1982; 79: 153–158
   PubMed Web of Science ®Google Scholar
• Arango M., Yarzabal L. T-cell dysfunction and hyperimmunoglobulinemia E in paracoccidioidomycosis. Mycopathologia 1982; 79: 115–124
   PubMed Web of Science ®Google Scholar
• Biagioni L., Souza M.J., Chamma L.G., Mendes R.P., Marques S.A., Mota N.G.S., Franco M. Serology of paracoccidioidomycosis. II. Correlation between class-specific antibodies and clinical forms of the disease. Transactions of the Royal Society of Tropical Medicine and Hygiene 1984; 78: 617–621
   PubMed Web of Science ®Google Scholar
• Calich V.L.G., Kipnis T.L., Mariano M., Fava Netto C., Dias da silva W. The activation of the complement system by P. brasiliensis in vitro: its opsonic effect and possible significance for an in vivo model of infection. Clinical Immunology and Immunopathology 1979; 12: 20–30
   Google Scholar
• Chequer-Bou-Habib D., Oliveira-Neto M.P., Ferreira-da-Cruz M.F., Galvão-Castro B. The possible role of circulating immune complexes in the deficiency of cell-mediated immunity in paracoccidioidomycosis. Brazilian Journal of Medical and Biological Research 1989; 22: 205–212
   PubMed Web of Science ®Google Scholar
• Diamond R.D., May J.E., Kame M.A., Frank M.M., Bennett J.E. The role of the classical and alternative complement pathways in host defenses against Cryptococcus neoformans infection. Journal of Immunology 1974; 112: 2260–2270
   PubMed Web of Science ®Google Scholar
• Fava Netto C. Estudos quantitativos sobre a fixação do complemento na Blastomicose Sul-Americana, com antígeno polissacarídico. Arquivos de Cirurgia e Clinica Experimental 1955; 18: 197–254
   PubMedGoogle Scholar
• Fava Netto C., Vegas V.S., Scianamea I.M., Guarnieri D.B. Antígeno polissacarídico do P. brasiliensis. Estudo do tempo de cultivo do P. brasiliensis necessário ao preparo do antígeno. Revista do Instituto de Medicina Tropical de São Paulo 1969; 11: 177–183
   PubMedGoogle Scholar
• Franco M. Host-parasite relationships in paracoccidioidomycosis. Journal of Medical and Veterinary Mycology 1986; 25: 5–18
   Google Scholar
• Frank M.M. Complement in the pathophysiology of human disease. New England Journal of Medicine 1987; 316: 1525–1530
   PubMed Web of Science ®Google Scholar
• Kajdacsy-Balla A., Doi E.M., Bagasra O. Activation of factor B of the alternative pathway of complement. American Journal of Clinical Pathology 1987; 88: 66–73
   PubMed Web of Science ®Google Scholar
• Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analytical Biochemistry 1966; 15: 45–52
   PubMed Web of Science ®Google Scholar
• Messias, de I.T., Santamaria J., Ragiotto R., Doi E.M., Kajdacsy-Balla A. Complement activation in Brazilian pemphigus foliaceus. Clinical and Experimental Dermatology 1989; 14: 51–55
   PubMed Web of Science ®Google Scholar
• Milgrom H., Curd J.G., Kaplan R.A., Müller-Eberhard H.J., Vaughan J.H. Activation of the fourth component of complement (C4). Assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4. Journal of Immunology 1980; 124: 2780–2785
   PubMed Web of Science ®Google Scholar
• Miller M.E., Nilsson U.R. A familial deficiency of the phagocytosis activity of serum related to a dysfunction of the fifth component of complement (C5). New England Journal of Medicine 1970; 282: 354–358
   PubMed Web of Science ®Google Scholar
• Mota N.G.S., Rezkallah-Iwasso M.T., Perasoli M.T.S., Audi R.C., Mendes R.P., Marcondes J., Marques S.A., Dillon N.L., Franco M.F. Correlation between cell-mediated immunity and clinical forms of paracoccidioidomycosis. Transactions of the Royal Society of Tropical Medicine and Hygiene 1985; 79: 765–772
   PubMed Web of Science ®Google Scholar
• Musatti C.C., Rezkallah M.T., Mendes E., Mendes N.F. In vivo and in vitro evaluation of cell-mediated immunity in patients with paracoccidioidomycosis. Cellular Immunology 1976; 24: 365–378
   PubMed Web of Science ®Google Scholar
• Restrepo A., Restrepo M., Restrepo F., Aristizabal L.H., Velez J. Immune response in paracoccidioidomycosis. A controlled study of 16 patients before and after treatment. Sabouraudia 1978; 16: 151–163
   PubMedGoogle Scholar
• Ribeiro M.G.A., Fava Netto C. Complemento hemolítico total e os components C3 e C7 em pacientes de paracoccidioidomicose. Revista do Instituto de Medicina Tropical 1981; 23: 106–110
   PubMedGoogle Scholar
• Sohnle P.G., Frank M.M., Kirpatrick C.H. Mechanisms involved in elimination of organisms from experimental cutaneous Candida albicans infections in guinea pigs. Journal of Immunology 1976; 117: 523–530
   PubMed Web of Science ®Google Scholar